These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4570236)

  • 21. Catecholamines in the brains of genetically obese rats.
    Cruce JA; Thoa NB; Jacobowitz DM
    Brain Res; 1976 Jan; 101(1):165-70. PubMed ID: 1244216
    [No Abstract]   [Full Text] [Related]  

  • 22. Central action of 11-(3-dimethylaminopropylidene)-6,11-dihydro-dibenzo-(b,e)oxepine hydrocholoride (doxepine).
    Zieliński M; Janiec W; Herman ZS
    Pol J Pharmacol Pharm; 1973; 25(1):17-22. PubMed ID: 4149574
    [No Abstract]   [Full Text] [Related]  

  • 23. [Variations of monoamines induced by p-chloro N-methylamphetamine in different parts of the rat brain].
    Boissier JR; Simon P; Guernet M; Tillement JP
    C R Acad Hebd Seances Acad Sci D; 1969 May; 268(18):2298-300. PubMed ID: 4980248
    [No Abstract]   [Full Text] [Related]  

  • 24. Noradrenaline and 5-hydroxytryptamine metabolism in six areas of rat brain during post-amphethamine depression.
    Tonge SR
    Psychopharmacologia; 1974; 38(2):181-6. PubMed ID: 4477665
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of morphine and pentazocine on the turnover of noradrenaline and dopamine in various regions of the rat brain.
    Sugrue MF
    Br J Pharmacol; 1973 Mar; 47(3):644P. PubMed ID: 4730858
    [No Abstract]   [Full Text] [Related]  

  • 26. Alterations in brain monoaminergic functioning associated with septal lesion induced hyperreactivity.
    Bernard BK; Berchek JR; Yutzey DA
    Pharmacol Biochem Behav; 1975; 3(1):121-6. PubMed ID: 1129348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral catecholamines after levodopa therapy.
    Greer M; Collins GH; Anton AH
    Arch Neurol; 1971 Nov; 25(5):461-7. PubMed ID: 5110888
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurochemical correlates of attention deficit disorder.
    Raskin LA; Shaywitz SE; Shaywitz BA; Anderson GM; Cohen DJ
    Pediatr Clin North Am; 1984 Apr; 31(2):387-96. PubMed ID: 6728523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug therapy in minimal brain dysfunction: a commentary.
    Erenberg G
    J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental changes in rat brain epinephrine levels.
    Milby KH; Mefford IN; Keller RW; Adams RN
    Brain Res; 1979 Jun; 169(2):398-400. PubMed ID: 445163
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
    Snyder SH; Taylor KM; Horn AS; Coyle JT
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():359-75. PubMed ID: 4341952
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential effect of amphetamine optical isomers on Bender Gestalt performance of the minimally brain dysfunctioned.
    Arnold LE; Huestis RD; Wemmer D; Smeltzer DJ
    J Learn Disabil; 1978 Mar; 11(3):127-32. PubMed ID: 353207
    [No Abstract]   [Full Text] [Related]  

  • 34. Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.
    Javoy F; Hamon M; Glowinski J
    Eur J Pharmacol; 1970 May; 10(2):178-88. PubMed ID: 4393431
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
    Shekim WO; Javaid J; Dekirmenjian H; Chapel JL; Davis JM
    Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A; Stenevi U
    Acta Physiol Scand Suppl; 1971; 373():1-15. PubMed ID: 5291907
    [No Abstract]   [Full Text] [Related]  

  • 37. Norepinephrine uptake by cerebral synaptosomes of mouse: strain differences.
    Moisset B; Hendley ED; Welch BL
    Brain Res; 1975 Jul; 92(1):157-64. PubMed ID: 1174943
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.